Oral contraceptives and the risk of endometrial cancer

Fabio Levi, Crrlo La Vecchia, Cristina Gulie, Eva Negri, Véronique Monnier, Silvia Franceschi, Jean Francois Delaloye, Pierre De Grandi

Research output: Contribution to journalArticle

Abstract

The relationship between the use of combbination oral contraceptives (OCs) and the risk of endometrial cancer was assessed in a case-control study conducted in the Swiss Canton of Vaud between 1 January 1988 and 31 July 1990. Subjects included 122 women aged 75 or less with histologically confirmed endometrial cancer, and 309 control women in hospital for acute conditions unrelated to OC use. Overall, 14 percent of cases and 27 percent of controls had ever used OCs, corresponding to a multivariate relative risk (RR) of 0.5 (95 percent confidence interval [CI]: 0.3. 0.8). The risk of endometrial cancer was found to be related inversely to duration of OC use: RR=1.0 for less than two years of OC use; 0.5 for two to five years; and 0.3 (95 percent CI: 0.1, 0.7) for more than five years. The protection appeared greater within 20 years since last use, and the RR rose to 0.8 after 20 or more years since last use; numbers are too small, however, for reliable inference from these subanalyses. No significant interaction or modifying effect was observed with other major factors related to endometrial cancer, including parity, body mass index, estrogen replacement therapy, and cigarette smoking. While this study provides further evidence for the protective effect of OCs against risk of endometrial cancer, the relationship requires continued evaluation to assess the long-term implications and public health impact of OC use.

Original languageEnglish
Pages (from-to)99-103
Number of pages5
JournalCancer Causes and Control
Volume2
Issue number2
DOIs
Publication statusPublished - Mar 1991

Fingerprint

Endometrial Neoplasms
Oral Contraceptives
Confidence Intervals
Estrogen Replacement Therapy
Parity
Case-Control Studies
Body Mass Index
Public Health
Smoking

Keywords

  • Case-control study
  • endometrial cancer
  • oral contraceptives
  • Switzerland

ASJC Scopus subject areas

  • Oncology
  • Epidemiology
  • Cancer Research

Cite this

Levi, F., La Vecchia, C., Gulie, C., Negri, E., Monnier, V., Franceschi, S., ... De Grandi, P. (1991). Oral contraceptives and the risk of endometrial cancer. Cancer Causes and Control, 2(2), 99-103. https://doi.org/10.1007/BF00053128

Oral contraceptives and the risk of endometrial cancer. / Levi, Fabio; La Vecchia, Crrlo; Gulie, Cristina; Negri, Eva; Monnier, Véronique; Franceschi, Silvia; Delaloye, Jean Francois; De Grandi, Pierre.

In: Cancer Causes and Control, Vol. 2, No. 2, 03.1991, p. 99-103.

Research output: Contribution to journalArticle

Levi, F, La Vecchia, C, Gulie, C, Negri, E, Monnier, V, Franceschi, S, Delaloye, JF & De Grandi, P 1991, 'Oral contraceptives and the risk of endometrial cancer', Cancer Causes and Control, vol. 2, no. 2, pp. 99-103. https://doi.org/10.1007/BF00053128
Levi F, La Vecchia C, Gulie C, Negri E, Monnier V, Franceschi S et al. Oral contraceptives and the risk of endometrial cancer. Cancer Causes and Control. 1991 Mar;2(2):99-103. https://doi.org/10.1007/BF00053128
Levi, Fabio ; La Vecchia, Crrlo ; Gulie, Cristina ; Negri, Eva ; Monnier, Véronique ; Franceschi, Silvia ; Delaloye, Jean Francois ; De Grandi, Pierre. / Oral contraceptives and the risk of endometrial cancer. In: Cancer Causes and Control. 1991 ; Vol. 2, No. 2. pp. 99-103.
@article{ae8acc40b7624b42a94ff2483ac5f3e4,
title = "Oral contraceptives and the risk of endometrial cancer",
abstract = "The relationship between the use of combbination oral contraceptives (OCs) and the risk of endometrial cancer was assessed in a case-control study conducted in the Swiss Canton of Vaud between 1 January 1988 and 31 July 1990. Subjects included 122 women aged 75 or less with histologically confirmed endometrial cancer, and 309 control women in hospital for acute conditions unrelated to OC use. Overall, 14 percent of cases and 27 percent of controls had ever used OCs, corresponding to a multivariate relative risk (RR) of 0.5 (95 percent confidence interval [CI]: 0.3. 0.8). The risk of endometrial cancer was found to be related inversely to duration of OC use: RR=1.0 for less than two years of OC use; 0.5 for two to five years; and 0.3 (95 percent CI: 0.1, 0.7) for more than five years. The protection appeared greater within 20 years since last use, and the RR rose to 0.8 after 20 or more years since last use; numbers are too small, however, for reliable inference from these subanalyses. No significant interaction or modifying effect was observed with other major factors related to endometrial cancer, including parity, body mass index, estrogen replacement therapy, and cigarette smoking. While this study provides further evidence for the protective effect of OCs against risk of endometrial cancer, the relationship requires continued evaluation to assess the long-term implications and public health impact of OC use.",
keywords = "Case-control study, endometrial cancer, oral contraceptives, Switzerland",
author = "Fabio Levi and {La Vecchia}, Crrlo and Cristina Gulie and Eva Negri and V{\'e}ronique Monnier and Silvia Franceschi and Delaloye, {Jean Francois} and {De Grandi}, Pierre",
year = "1991",
month = "3",
doi = "10.1007/BF00053128",
language = "English",
volume = "2",
pages = "99--103",
journal = "Cancer Causes and Control",
issn = "0957-5243",
publisher = "Springer International Publishing AG",
number = "2",

}

TY - JOUR

T1 - Oral contraceptives and the risk of endometrial cancer

AU - Levi, Fabio

AU - La Vecchia, Crrlo

AU - Gulie, Cristina

AU - Negri, Eva

AU - Monnier, Véronique

AU - Franceschi, Silvia

AU - Delaloye, Jean Francois

AU - De Grandi, Pierre

PY - 1991/3

Y1 - 1991/3

N2 - The relationship between the use of combbination oral contraceptives (OCs) and the risk of endometrial cancer was assessed in a case-control study conducted in the Swiss Canton of Vaud between 1 January 1988 and 31 July 1990. Subjects included 122 women aged 75 or less with histologically confirmed endometrial cancer, and 309 control women in hospital for acute conditions unrelated to OC use. Overall, 14 percent of cases and 27 percent of controls had ever used OCs, corresponding to a multivariate relative risk (RR) of 0.5 (95 percent confidence interval [CI]: 0.3. 0.8). The risk of endometrial cancer was found to be related inversely to duration of OC use: RR=1.0 for less than two years of OC use; 0.5 for two to five years; and 0.3 (95 percent CI: 0.1, 0.7) for more than five years. The protection appeared greater within 20 years since last use, and the RR rose to 0.8 after 20 or more years since last use; numbers are too small, however, for reliable inference from these subanalyses. No significant interaction or modifying effect was observed with other major factors related to endometrial cancer, including parity, body mass index, estrogen replacement therapy, and cigarette smoking. While this study provides further evidence for the protective effect of OCs against risk of endometrial cancer, the relationship requires continued evaluation to assess the long-term implications and public health impact of OC use.

AB - The relationship between the use of combbination oral contraceptives (OCs) and the risk of endometrial cancer was assessed in a case-control study conducted in the Swiss Canton of Vaud between 1 January 1988 and 31 July 1990. Subjects included 122 women aged 75 or less with histologically confirmed endometrial cancer, and 309 control women in hospital for acute conditions unrelated to OC use. Overall, 14 percent of cases and 27 percent of controls had ever used OCs, corresponding to a multivariate relative risk (RR) of 0.5 (95 percent confidence interval [CI]: 0.3. 0.8). The risk of endometrial cancer was found to be related inversely to duration of OC use: RR=1.0 for less than two years of OC use; 0.5 for two to five years; and 0.3 (95 percent CI: 0.1, 0.7) for more than five years. The protection appeared greater within 20 years since last use, and the RR rose to 0.8 after 20 or more years since last use; numbers are too small, however, for reliable inference from these subanalyses. No significant interaction or modifying effect was observed with other major factors related to endometrial cancer, including parity, body mass index, estrogen replacement therapy, and cigarette smoking. While this study provides further evidence for the protective effect of OCs against risk of endometrial cancer, the relationship requires continued evaluation to assess the long-term implications and public health impact of OC use.

KW - Case-control study

KW - endometrial cancer

KW - oral contraceptives

KW - Switzerland

UR - http://www.scopus.com/inward/record.url?scp=0026128744&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026128744&partnerID=8YFLogxK

U2 - 10.1007/BF00053128

DO - 10.1007/BF00053128

M3 - Article

C2 - 1873443

AN - SCOPUS:0026128744

VL - 2

SP - 99

EP - 103

JO - Cancer Causes and Control

JF - Cancer Causes and Control

SN - 0957-5243

IS - 2

ER -